Novavax Inc. Stock Slides 4.0%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Novavax Inc. slid 4.0% to $10.82 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 26,430.89 and the Dow Jones Industrial Average falling 0.1% to 51,966.03.

This was the stock's second consecutive day of losses.

Novavax Inc. closed 19.2% below its 52-week high of $13.39, which the company achieved on October 5th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.7% to $253.79, Pfizer Inc. fell 0.5% to $29.44, and Merck & Co. Inc. fell 1.59% to $143.63.

Trading volume totaled 6.2 million, compared to the 50-day average of 6.7 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 19, 2026 16:34 ET (20:34 GMT)